Clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor.

ABSTRACT:

Purpose

To evaluate the outcome of robot-assisted residual mass resection (RA-RMR) in nonseminomatous germ cell tumor (NSGCT) patients with residual tumor following chemotherapy.

Patients and methods

Retrospective medical chart analysis of all patients with NSGCT undergoing RA-RMR at two tertiary referral centers between January 2007 and April 2019. Patients were considered for RA-RMR in case of a residual tumor between 10 and 50 mm at cross-sectional computed tomography (CT) imaging located ventrally or laterally from the aorta or vena cava, with normalized tumor markers following completion of chemotherapy, and no history of retroperitoneal surgery.

Results

A total of 45 patients were included in the analysis. The Royal Marsden stage before chemotherapy was IIA in 1

SUBMITTER: Blok JM 

PROVIDER: S-EPMC8217018 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature